Market Tracker

09/19 9:52am ET

Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.7595
Real-Time Quote
 -0.0005 / -0.07%
Today’s Change
0.37
Today|||52-Week Range
1.85
+48.92%
Year-to-Date
No recent news for Rexahn Pharmaceuticals Inc.

Today’s Trading

Previous close0.76
Today’s open0.75
Day’s range0.75 - 0.78
Volume34,258
Average volume (3 months)1,031,721
Market cap$135.5M
Dividend yield--
Data as of 9:37am ET, 09/19/2014

Growth & Valuation

Earnings growth (last year)-16.67%
Earnings growth (this year)-61.90%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book8.83

Competitors

 Today’s
change
Today’s
% change
TNXPTonix Pharmaceutical...0.000.00%
CRMECardiome Pharma Corp0.000.00%
SRNESorrento Therapeutic...-0.08-1.64%
GLYCGlycoMimetics Inc0.000.00%
Data as of 9:37am ET, 09/19/2014

Financials

Next reporting dateDecember 3, 2014
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$0.00
Annual profit (last year)-$9.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Scientist
Chang Ho Ahn
Chief Executive Officer &
Director
Peter David Suzdak
Corporate headquarters
Rockville, Maryland

Forecasts